National Human Genome Research Institute; Notice of Closed Meeting, 62109-62110 [2022-22161]
Download as PDF
<![CDATA[
62109
Federal Register / Vol. 87, No. 197 / Thursday, October 13, 2022 / Notices
ANNUALIZED BURDEN HOUR TABLE—Continued
Type of
respondent
Section
164.504
Number of
respondents
Uses and Disclosures—Organizational Requirements.
Uses and Disclosures for Which Individual authorization is required.
Uses and Disclosures for Research Purposes
[12].
Notice of Privacy Practices for Protected Health
Information (health plans—periodic distribution
of NPPs by paper mail) [13], [18].
Notice of Privacy Practices for Protected Health
Information (health plans—periodic distribution
of NPPs by electronic mail) [19].
Notice of Privacy Practices for Protected Health
Information (health care providers—dissemination and acknowledgement) [14].
Rights to Request Privacy Protection for Protected Health Information [15].
Access of Individuals to Protected Health Information (disclosures) [16].
Amendment of Protected Health Information (requests).
Amendment of Protected Health Information (denials).
Accounting for Disclosures of Protected Health
Information [17].
164.508
164.512
164.520
164.520
164.520
164.522
164.524
164.526
164.526
164.528
Total .....................................................................
Sherrette A. Funn,
Paperwork Reduction Act Reports Clearance
Officer, Office of the Secretary.
[FR Doc. 2022–22204 Filed 10–12–22; 8:45 am]
BILLING CODE 4150–28–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Biomedical Advanced Research and
Development Authority Industry Day
2022
Administration for Strategic
Preparedness and Response (ASPR),
Department of Health and Human
Services (HHS).
AGENCY:
ACTION:
Notice.
The Biomedical Advanced
Research and Development Authority
(BARDA) annually hosts BARDA
Industry Day (BID), a two-day
conference with our industry and
government partners to share BARDA’s
goals and objectives, increase awareness
of U.S. government medical
countermeasure (MCM) priorities, and
facilitate coordination and collaboration
between public and private sectors
within the health security space.
khammond on DSKJM1Z7X2PROD with NOTICES
SUMMARY:
BID 2022 will be held virtually
from Tuesday, November 15–
Wednesday, November 16, 2022. The
DATES:
VerDate Sep<11>2014
17:49 Oct 12, 2022
Jkt 259001
1
0.083333333
58,333
700,000
1
1
700,000
113,524
1
0.083333333
9,460
100,000,000
1
0.004166667
416,667
100,000,000
1
0.002783333
278,333
613,000,000
1
0.05
30,650,000
20,000
1
0.05
1,000
200,000
1
0.05
10,000
150,000
1
0.083333333
12,500
50,000
1
0.083333333
4,167
5,000
1
0.05
250
..............................
2,070
..............................
921,158,940
Dawn O’Connell,
Assistant Secretary for Preparedness and
Response.
[FR Doc. 2022–22169 Filed 10–12–22; 8:45 am]
BILLING CODE 4150–37–P
Frm 00044
Total burden
hours
700,000
meeting will begin each day at 9 a.m.
Eastern Standard Time.
ADDRESSES: Procedures for Public
Participation: This meeting is open to
the public. Register here: https://
www.medicalcountermeasures.gov/
barda/barda-industry-day-2022/.
FOR FURTHER INFORMATION CONTACT:
Ezinne N. Ebi, Biomedical Advanced
Research & Development Authority
(BARDA), ezinne.ebi@hhs.gov, (202)
989–5539.
SUPPLEMENTARY INFORMATION: This year,
BARDA plans to discuss the
organization’s new five-year strategic
plan, which focuses on strengthening
the health security of the nation,
embracing lessons learned from the
COVID–19 pandemic, incorporating
new avenues of promising research and
development, and addressing the
imperative for MCMs that are safe,
effective, and widely accessible to all
Americans. BID 2022 will be an exciting
opportunity to explore how the field of
MCMs is on the cutting edge of
innovation, and how we can work
together to prepare for 21st century
health security threats.
PO 00000
Average
burden hours per
response
[1]
Number of
responses per
respondent
Fmt 4703
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Human Genome Research
Institute; Notice of Closed Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, National Human Genome
Research Institute.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended for the review, discussion,
and evaluation of individual intramural
programs and projects conducted by the
NATIONAL HUMAN GENOME
RESEARCH INSTITUTE, including
consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, National Human Genome
Research Institute.
Date: November 16–17, 2022.
Time: 2:20 p.m. to 2:45 p.m.
Agenda: To review and evaluate personnel
qualifications and performance, and
competence of individual investigators.
E:\FR\FM\13OCN1.SGM
13OCN1
62110
Federal Register / Vol. 87, No. 197 / Thursday, October 13, 2022 / Notices
Place: National Human Genome Research
Institute, National Institutes of Health,
Building 50, 50 Center Drive, Room 5222C,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Paul Liu, Ph.D., MD,
Deputy Scientific Director, National Human
Genome Research Institute, National
Institutes of Health, Building 50, 50 Center
Drive, Room 5222C, Bethesda, MD 20892,
(301) 402–2529, pliu@mail.nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.172, Human Genome
Research, National Institutes of Health, HHS)
Dated: October 6, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–22161 Filed 10–12–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
Center for Scientific Review; Notice of
Closed Meetings
khammond on DSKJM1Z7X2PROD with NOTICES
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meetings.
The meetings will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Population Sciences
and Epidemiology Integrated Review Group;
Population Based Research in Infectious
Disease Study Section.
Date: November 9–10, 2022.
Time: 10 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Lisa Steele, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 3139,
MSC 7770, Bethesda, MD 20892, (301) 257–
2638, steeleln@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; RFA–OD–
21–004: Maximizing the Scientific Value of
Existing Biospecimen Collections (R21).
Date: November 9, 2022.
Time: 2 p.m. to 4 p.m.
Agenda: To review and evaluate grant
applications.
VerDate Sep<11>2014
17:49 Oct 12, 2022
Jkt 259001
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Atul Sahai, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 2188,
MSC 7818, Bethesda, MD 20892, 301–435–
1198, sahaia@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Health Services and Systems.
Date: November 10, 2022.
Time: 9 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Wenjuan Wang, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institute of
Health, 6701 Rockledge Drive, Room 3154,
Bethesda, MD 20892, (301) 480–8667,
wangw22@mail.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business: SBIR/STTR Commercialization
Readiness Pilot (CRP) Program.
Date: November 10, 2022.
Time: 9:30 a.m. to 6 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health
Rockledge II 6701 Rockledge Drive Bethesda,
MD 20892 (Virtual Meeting).
Contact Person: Allen B. Richon, Ph.D., BS,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 6184,
MSC 7892, Bethesda, MD 20892, (240) 760–
0517, allen.richon@nih.hhs.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Biobehavioral Processes.
Date: November 10, 2022.
Time: 9:30 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Hoa Thi Vo, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 1002B2,
Bethesda, MD 20892, (301) 594–0776, voht@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Member
Conflict: Topics in Early Stress,
Psychopathology, and Developmental
Disabilities.
Date: November 10, 2022.
Time: 10 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Rochelle Francine
Hentges, Ph.D., Scientific Review Officer,
Center for Scientific Review, National
Institutes of Health, 6701 Rockledge Drive,
Room 1000C, Bethesda, MD 20892, (301)
402–8720, hentgesrf@mail.nih.gov.
PO 00000
Frm 00045
Fmt 4703
Sfmt 4703
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Shared
Instrumentation: Flow Cytometry.
Date: November 10, 2022.
Time: 10 a.m. to 7 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Robert O’Hagan, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (240) 909–6378, ohaganr2@
csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel; Small
Business Endocrine and Metabolic Systems.
Date: November 10, 2022.
Time: 10 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health,
Rockledge II, 6701 Rockledge Drive,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Baskaran Thyagarajan,
Ph.D., Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Room 800B,
Bethesda, MD 20892, (301) 867–5309,
thyagarajanb2@csr.nih.gov.
Name of Committee: Center for Scientific
Review Special Emphasis Panel;
Neurological and Neuropsychological
Injuries and Disorders.
Date: November 10, 2022.
Time: 10 a.m. to 8 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institutes of Health, 6701
Rockledge Drive, Bethesda, MD 20892
(Virtual Meeting).
Contact Person: Todd Everett White, Ph.D.,
Scientific Review Officer, Center for
Scientific Review, National Institutes of
Health, 6701 Rockledge Drive, Bethesda, MD
20892, (301) 594–3962, todd.white@nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.306, Comparative Medicine;
93.333, Clinical Research, 93.306, 93.333,
93.337, 93.393–93.396, 93.837–93.844,
93.846–93.878, 93.892, 93.893, National
Institutes of Health, HHS.)
Dated: October 6, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2022–22219 Filed 10–12–22; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOMELAND
SECURITY
Coast Guard
[Docket No. USCG–2022–0701]
National Chemical Transportation
Safety Advisory Committee; November
2022 Meeting
U.S. Coast Guard, Department
of Homeland Security.
AGENCY:
E:\FR\FM\13OCN1.SGM
13OCN1
]]>Agencies
[Federal Register Volume 87, Number 197 (Thursday, October 13, 2022)]
[Notices]
[Pages 62109-62110]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-22161]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Human Genome Research Institute; Notice of Closed
Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of a meeting of the Board of Scientific
Counselors, National Human Genome Research Institute.
The meeting will be closed to the public as indicated below in
accordance with the provisions set forth in sections 552b(c)(4) and
552b(c)(6), Title 5 U.S.C., as amended for the review, discussion, and
evaluation of individual intramural programs and projects conducted by
the NATIONAL HUMAN GENOME RESEARCH INSTITUTE, including consideration
of personnel qualifications and performance, and the competence of
individual investigators, the disclosure of which would constitute a
clearly unwarranted invasion of personal privacy.
Name of Committee: Board of Scientific Counselors, National
Human Genome Research Institute.
Date: November 16-17, 2022.
Time: 2:20 p.m. to 2:45 p.m.
Agenda: To review and evaluate personnel qualifications and
performance, and competence of individual investigators.
[[Page 62110]]
Place: National Human Genome Research Institute, National
Institutes of Health, Building 50, 50 Center Drive, Room 5222C,
Bethesda, MD 20892 (Virtual Meeting).
Contact Person: Paul Liu, Ph.D., MD, Deputy Scientific Director,
National Human Genome Research Institute, National Institutes of
Health, Building 50, 50 Center Drive, Room 5222C, Bethesda, MD
20892, (301) 402-2529, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.172, Human
Genome Research, National Institutes of Health, HHS)
Dated: October 6, 2022.
Melanie J. Pantoja,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2022-22161 Filed 10-12-22; 8:45 am]
BILLING CODE 4140-01-P
